Esther Vinarov

CMS Innovation Center Announces Cost-Saving Restructuring Of Value-Based Payment Model Portfolio

FDA's New Human Foods Program: Enhancing Post-Market Safety Assessments Of Chemicals In Food

FDA On Board With Continuing Remote Inspections

FDA Final Rule: IRB Waiver Of Informed Consent For Minimal-Risk Investigations

FDA Announces Delayed Enforcement Of Looming Supply Chain Requirements For Drugs Until 2024

FDA Proposes Updated Definition Of "Healthy" Claim For Food